Funder
Pharmaceutical Research and Manufacturers of America Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference50 articles.
1. Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer’s disease drug development pipeline: 2020. Alzheimer’s Dement. 2020;6:e12050.
2. Lin PJ, Cohen JT, Neumann PJ. Preparing the health-care system to pay for new Alzheimer’s drugs. Alzheimer’s Dement. 2020;16:1568–70.
3. Rainville C, Skufca L, Mehegan L. Family caregiving and out-of-pocket costs: 2016 report [Internet]. Washington, DC: AARP; 2016. https://doi.org/10.26419/res.00138.001.
4. Kasper JD, Freedman VA, Spillman BC, Wolff JL. The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Aff. 2015;34:1642–9.
5. Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, et al. Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ Rev. 2012;2:1–12.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献